IntelliRay
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IntelliRay - overview
Established
2018
Location
Shenyang, Liaoning, China
Primary Industry
Healthcare Specialists
About
Founded in 2018 and based in Shenyang, China, IntelliRay is a medical company that focuses on the research and development of oncology radiotherapy technologies, products, and solutions. The company is the wholly owned subsidiary of Neusoft Medical. IntelliRay was recognized as the National High-tech Enterprise. The company has more than 40 patents.
It cooperated with In Sun Yat-sen University Cancer Center, China Electronics Technology Group Corporation, Southern Medical University, etc. The company has 37 service teams and 21 spare parts centers at home and abroad. Shaojie Wu, the chairman of the company, used to work in Shanghai Neusoft Medical Equipment and other companies. In June 2024, IntelliRay raised a series C funding for over CNY 100 million.
IntelliRay mainly provides oncology radiotherapy solutions based on artificial intelligence, cloud computing, and other technologies. Its products include NeuRT Aurora Smart Radiotherapy Platforms, NeuOIS Polaris Aurora Oncology Information Systems, and NeuOIS Cloud Aurora Remote Radiotherapy Platforms. The NeuRT Aurora Smart Radiotherapy Platforms are equipped with fiber-optic distributed real-time control systems (RTCS) and iCBCT diagnostic-grade image guidance systems, which adopt Spiral Volume Modulation Therapy (SVMAT) technology. Products and solutions mainly serve oncology patients.
The company generates revenue by providing oncology radiotherapy products and solutions. The company will use the series C funding to develop radiotherapy equipment and information technology systems, expand markets, and construct new industrial bases, etc.
Current Investors
Neusoft Venture Capital, Yueli Capital, Ivy Capital
Primary Industry
Healthcare Specialists
Sub Industries
Healthcare IT, Oncology/Cancer Treatment, Medical Equipment Distributors, Web Applications, Medical Software
Website
www.intelliray.com.cn
Verticals
Artificial Intelligence, Cloud Computing, HealthTech, Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.